The Russian pharmaceutical market is developing rapidly; it takes 11th place in the rating of pharmaceutical market volumes worldwide and is predicted to go up to 9th place by 2016. Along with its growing potential, important changes in the industry have taken place due to the government program “Pharma 2020”.
With all the evidence pointing at Russia as a location with a rapidly developing pharma industry and with quality issues being a central theme, Fleming Europe has decided to organize a conference on Quality Assurance in Russian Pharma Manufacturing.
Experts from Johnson & Johnson, Novartis, Bayer Healthcare, Novo Nordisk, Akrikhin, Stada CIS, Vertex, R-Pharm and others will gather on 27 – 28 May 2015 in Moscow to discuss how to ensure a level of quality, and therefore guarantee drug safety, lower production risks, and increase sales.
During the two interactive days, attendees will have the opportunity to learn from case studies, gain insights and learn from best practitioners, get tangible and hands-on knowledge, meet industry professionals, and discover innovative approaches to quality assurance in other industries.
GMP experts and company representatives will reveal their best practices of GMP implementation and representatives from Russian regulatory bodies will provide updates on governmental regulations. Speakers from Akrikhin will lead a hands-on workshop on building a risk management system, representatives from Johnson & Johnson, Bayer Healthcare and Petrovax will explain how to spread and include quality system principles into all processes of the company and much more!
The full event program may be downloaded here
For more information, please visit: http://flemingeurope.com/